TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 79 filers reported holding TRINITY BIOTECH PLC in Q3 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,062,000 | +14.8% | 80,370 | -1.5% | 0.30% | +10.1% |
| Q2 2016 | $925,000 | -9.2% | 81,579 | -6.7% | 0.28% | -10.1% |
| Q1 2016 | $1,019,000 | +15.1% | 87,397 | +16.1% | 0.31% | +18.5% |
| Q4 2015 | $885,000 | +25.2% | 75,296 | +21.9% | 0.26% | +20.9% |
| Q3 2015 | $707,000 | -36.6% | 61,769 | 0.0% | 0.22% | +25.0% |
| Q2 2015 | $1,116,000 | -6.1% | 61,769 | 0.0% | 0.17% | -53.1% |
| Q1 2015 | $1,189,000 | -3.7% | 61,769 | -12.4% | 0.37% | -3.2% |
| Q4 2014 | $1,235,000 | +18.8% | 70,541 | +23.9% | 0.38% | +26.8% |
| Q3 2014 | $1,040,000 | -11.0% | 56,914 | +12.2% | 0.30% | -9.4% |
| Q2 2014 | $1,168,000 | -5.0% | 50,714 | 0.0% | 0.33% | -7.6% |
| Q1 2014 | $1,229,000 | -26.2% | 50,714 | -23.4% | 0.36% | -28.6% |
| Q4 2013 | $1,665,000 | -0.1% | 66,214 | -13.6% | 0.50% | -17.6% |
| Q3 2013 | $1,667,000 | +14.1% | 76,607 | -11.6% | 0.61% | +24.9% |
| Q2 2013 | $1,461,000 | – | 86,682 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |